Mepolizumab effectiveness for patients with severe, uncontrolled chronic rhinosinusitis with nasal polyps in Italy (MEPOREAL): a real-life, multicentre, phase 4 trial

Study limitation reported by the research below: “'On the way to remission' is a surrogate endpoint defined by the authors and may not align with established remission definitions used in other trials.”